Recent Security Class Actions

Applied Therapeutics Inc. Common Stock (NASDAQ: APLT)

37 Days left to seek lead plaintiff status.

Company Name:Applied Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: APLT
Class Period Start:01/03/2024
Class Period End (inclusive):12/02/2024
Filing Deadline:02/17/2025

The Complaint alleges that Defendants provided positive statements to investors while, at the same time, disseminating false and materially misleading statements and/or concealing material adverse facts concerning the true state of Applied Therapeutics’ Phase III INSPIRE trial; notably, electronic data capture issues and a dosing error in the dose-escalation phase of the study. The Complaint further alleges that such statements absent these material facts caused Plaintiff and other shareholders to purchase Applied Therapeutics’ securities at artificially inflated prices.

Applied Therapeutics Inc. Common Stock (NASDAQ: APLT) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.